By Peter A. McCullough, MD, MPH
I recently had a young male patient with the clinical diagnosis of COVID-19 mRNA COVID-19 vaccine myocarditis in 2021 develop recurring symptoms in 2025. His cardiac MRI demonstrated late gadolinium enhancement indicative of either ongoing inflammation cardiac scar.
Warren et al studied 67 young Australian victims of COVID-19 vaccine myopericarditis hospitalizations after taking the shot.
67 patients with C-VAM (mean age 30±13 years, 72% male) underwent CMR evaluation. The median time from vaccination to CMR was 548 (range 398-603) days. 20 patients (30%) had LGE. At diagnosis, nine patients (13%) were classified as definite and 58 (87%) as probable myocarditis. With the integration of CMR-LGE data, 16 patients (28%) were reclassified from probable to definite myocarditis. LGE on CMR occurred in one-third of patients with C-VAM.
Click this link for the original source of this article.
Author: Peter A. McCullough, MD, MPH
This content is courtesy of, and owned and copyrighted by, https://petermcculloughmd.substack.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
